Skip to Content

Royal Caribbean Group

RCL: XNYS (USA)
View Stock Summary
Morningstar Rating for Stocks Fair Value Economic Moat Capital Allocation
$538.00RwztbhbRjqgjxkth

Improving EBITDA Growth Set to Persist at Royal Caribbean With Full Fleet Deployed

Business Strategy and Outlook

Travel constraints and coronavirus hesitancy are receding, so consumer behavior about travel and social distancing have returned to normal for Royal Caribbean, leading to positive operating cash flow and EBITDA at the business. The redeployment of the fleet is complete, and cruise operators have successfully implemented health protocols to ensure the safety of the cruising population (as evidenced by a lower positivity rate than on land). With virus restrictions largely in the rearview mirror, Royal Caribbean should see modest pricing gains as it digests bookings paid for with future cruise credits and takes new reservations. On the cost side, some health protocols and cruise resumption costs could reman high in near-term spending, but should pare back in 2023, aiding profitability.

Free Trial of Morningstar Investor

Get our analysts’ objective, in-depth, and continuous investment coverage of RCL so you can make buy / sell decisions free of market noise.

Start Free Trial

Sponsor Center